Clinical Trial Update: Oxytocin in Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the use of oxytocin during cesarean delivery for postpartum hemorrhage. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Post Partum Hemorrhage | Phase 4 | Status: UNKNOWN